Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Liabilities (2020 - 2025)

Journey Medical's Total Liabilities history spans 6 years, with the latest figure at $62.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 4.26% year-over-year to $62.7 million, compared with a TTM value of $62.7 million through Dec 2025, up 4.26%, and an annual FY2025 reading of $62.7 million, up 4.26% over the prior year.
  • Total Liabilities for Q4 2025 was $62.7 million at Journey Medical, up from $59.3 million in the prior quarter.
  • The five-year high for Total Liabilities was $100.8 million in Q3 2021, with the low at -$10.8 million in Q1 2021.
  • Average Total Liabilities over 5 years is $60.3 million, with a median of $61.0 million recorded in 2024.
  • Year-over-year, Total Liabilities soared 9836.99% in 2022 and then plummeted 40.77% in 2023.
  • Tracing DERM's Total Liabilities over 5 years: stood at $55.2 million in 2021, then surged by 59.62% to $88.2 million in 2022, then crashed by 35.93% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024, then increased by 4.26% to $62.7 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Total Liabilities are $62.7 million (Q4 2025), $59.3 million (Q3 2025), and $61.9 million (Q2 2025).